On the use of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of influenza vaccine effectiveness.
暂无分享,去创建一个
[1] G. Tannock,et al. Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population. , 1984, Vaccine.
[2] Frank L. Horsfall,et al. PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A VIRUSES AFTER INCOMPLETE NEUTRALIZATION IN OVO WITH HETEROLOGOUS IMMUNE SERUM , 1950, The Journal of experimental medicine.
[3] E. Leiderman,et al. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. , 1970, JAMA.
[4] P Scott. Firepower in the Lab: Automation in the Fight Against Infectious Diseases and Bioterrorism , 2001 .
[5] J. S. Neill,et al. An evaluation of influenza immunization: influence of route of administration and vaccine strain. , 1969, Bulletin of the World Health Organization.
[6] P. Underwood. Serology and energetics of cross-reactions among the H3 antigens of influenza viruses. , 1980, Infection and immunity.
[7] Yoshihiro Kawaoka,et al. Influenza Virology: Current Topics , 2006 .
[8] R B Couch,et al. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. , 1988, American journal of epidemiology.
[9] Cecile Viboud,et al. Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data. , 2006, American journal of epidemiology.
[10] S. Kashiwagi,et al. A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. , 2003, Vaccine.
[11] Michael W. Deem,et al. Entropy, disease, and new opportunities for chemical engineering research , 2005 .
[12] J. Shemer,et al. Influenza vaccine efficacy in young, healthy adults. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] K. Nichol,et al. The effectiveness of vaccination against influenza in healthy, working adults. , 1995, The New England journal of medicine.
[14] M. Deem,et al. Epitope analysis for influenza vaccine design. , 2004, Vaccine.
[15] G. Barigazzi,et al. Antigenic and Genetic Evolution of Swine Influenza A (H3N2) Viruses in Europe , 2007, Journal of Virology.
[16] A. Douglas,et al. The evolution of human influenza viruses. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[17] A S Perelson,et al. Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. W. Smith,et al. Vaccination against influenza: a five-year study in the Post Office , 1979, Journal of Hygiene.
[19] A. L. Chan,et al. The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan , 2007, Pharmacy World & Science.
[20] A. Detsky,et al. Use of, Effectiveness of, and Attitudes Regarding Influenza Vaccine Among House Staff , 2003, Infection Control & Hospital Epidemiology.
[21] S. Weingarten,et al. Do hospital employees benefit from the influenza vaccine? , 2007, Journal of General Internal Medicine.
[22] M. Halloran,et al. Design and interpretation of vaccine field studies. , 1999, Epidemiologic reviews.
[23] D. Campbell,et al. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. , 1997, Journal of occupational and environmental medicine.
[24] M. Galiano,et al. Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in Spain from 1996 to 2000 , 2001, Archives of Virology.
[25] T. Eddy,et al. The effect of vaccine on a closed epidemic of Hong Kong influenza. , 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[26] W. Dowdle,et al. Properties of the Hong Kong influenza virus. Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses. , 1969, Bulletin of the World Health Organization.
[27] M. Aymard,et al. Reduced efficiency of influenza vaccine in prevention of influenza-like illness in working adults: a 7 month prospective survey in EDF Gaz de France employees, in Rhône-Alpes, 1996-1997. , 2002, Occupational medicine.
[28] R. Belshe,et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. , 1995, The Journal of infectious diseases.
[29] S. Layne. Human Influenza Surveillance: the Demand to Expand , 2006, Emerging infectious diseases.
[30] E. Forleo-Neto,et al. Impact of influenza vaccination on civilian aircrew illness and absenteeism. , 2002, Aviation, space, and environmental medicine.
[31] R B Couch,et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.
[32] W. J. Coggins,et al. Influenza immunization: field trial on a university campus. , 1972, The Journal of infectious diseases.
[33] J. Salk,et al. A critique of serologic methods for the study of influenza viruses , 2005, Archiv für die gesamte Virusforschung.
[34] G. K. Hirst. THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS. , 1941, Science.
[35] Michael W Deem,et al. Quantifying influenza vaccine efficacy and antigenic distance. , 2005, Vaccine.
[36] W. Dupont,et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. , 1994, The Journal of infectious diseases.
[37] W. O'Fallon,et al. Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals , 2001, Journal of Virology.
[38] M. Meltzer,et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. , 2000, JAMA.
[39] A. Fauci,et al. The next influenza pandemic: can it be predicted? , 2007, JAMA.
[40] N. Cox,et al. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites , 1983, Journal of virology.
[41] A. Lapedes,et al. Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.
[42] Uenza Manu. WHO Manual on Animal Influenza Diagnosis and Surveillance , 2002 .
[43] Min-Shi Lee,et al. Predicting Antigenic Variants of Influenza A/H3N2 Viruses , 2004, Emerging infectious diseases.
[44] Douglas G. Bonett,et al. Estimating the ratio of two Poisson rates , 2000 .
[45] Y. Kawaoka,et al. Epidemiology and control of human and animal influenza. , 2006 .